Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1971-7-29
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0028-3878
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
550-2
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:5104099-Acute Disease,
pubmed-meshheading:5104099-Carbon Isotopes,
pubmed-meshheading:5104099-Chromatography,
pubmed-meshheading:5104099-Edrophonium,
pubmed-meshheading:5104099-Humans,
pubmed-meshheading:5104099-Injections, Intravenous,
pubmed-meshheading:5104099-Myasthenia Gravis,
pubmed-meshheading:5104099-Pyridostigmine Bromide
|
| pubmed:year |
1971
|
| pubmed:articleTitle |
The effect of chronic pyridostigmine administration on pyridostigmine-14C metabolism in myasthenia gravis.
|
| pubmed:publicationType |
Journal Article
|